Navigation Links
Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting
Date:12/7/2009

SEATTLE and REDWOOD CITY, Calif., Dec. 7 /PRNewswire-FirstCall/ --

Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) and Facet Biotech Corp. (Nasdaq: FACT) today announced the presentation of positive data from a phase 1 study of TRU-016 in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) at the 2009 American Society of Hematology (ASH) Annual Meeting. TRU-016 is a CD37-directed Small Modular ImmunoPharmaceutical (SMIP(TM)) protein therapeutic in development for the treatment of B-cell malignancies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091207/SF21859LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO)

"Unlike other peptide therapies that target CD20, TRU-016 targets CD37 and mediates both immune-mediated death and direct killing through a novel mechanism," said John Byrd, M.D., Interim co-director, Division of Hematology-Oncology, and Professor of Leukemia Research, Department of Internal Medicine at The Ohio State University. "The favorable toxicity profile and clinical activity with TRU-016 observed to date in this study suggests it has potential to be a major contributor to combination strategies that are impacting CLL treatment outcome."

Data were presented today for 33 patients enrolled in the phase 1 TRU-016 dose escalation trial (abstract 3424). A majority of patients (20/33) had high-risk genomic features associated
'/>"/>

SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
3. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
4. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
5. Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
6. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
7. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
8. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
9. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
10. Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting
11. Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Ill. , Aug. 22, 2014  Landauer, Inc. ... personal and environmental radiation measurement and monitoring, outsourced medical ... today that William E. Saxelby , its President ... President and Chief Executive Officer and as a member ... 15, 2014.  He will be replaced on an interim ...
(Date:8/22/2014)... -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the pricing ... stock and warrants at a price of $10,000 per ... deducting underwriting discounts and commissions and offering expenses payable ... separable and will be issued separately.  The shares of ... NASDAQ Stock Market under the ticker symbol "WGBS" on ...
(Date:8/21/2014)... 21, 2014   Memorial Hermann Health System and ... today announced a new partnership to provide a new level ... care centers in the greater Houston ... become the exclusive provider of professional breast radiology services for ... Memorial City, The Woodlands , Northeast, Southwest ...
Breaking Medicine Technology:Landauer, Inc. Announces Executive Management Change 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4
... 2011 The Myth that physicians workload lessens ... with the New Year quickly approaching physicians are preparing for ... RNCOS depicts Healthcare IT spending by physicians and other healthcare ... this year, with most of it attributed to electronic health ...
... Therapeutics, Inc. (PTC) today announced the receipt of ... from the Wellcome Trust to support the development ... by multidrug-resistant (MDR) Gram-negative bacteria.  PTC previously received ... Trust to support its BMI1 oncology program. ...
Cached Medicine Technology:Medicalbillersandcoders.com Puts its Service Offers to Physicians Who Strive to Streamline Their Practice This Holiday Season! 2Medicalbillersandcoders.com Puts its Service Offers to Physicians Who Strive to Streamline Their Practice This Holiday Season! 3Medicalbillersandcoders.com Puts its Service Offers to Physicians Who Strive to Streamline Their Practice This Holiday Season! 4PTC Therapeutics' Antibacterial Program Receives $5 Million Award from the Wellcome Trust 2
(Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... the recent past, specifically in the developing world, has ... infection and the number of deaths due to AIDS ... are declining, the number of new patients becoming affected ... the conscious efforts being undertaken by all related organisations ...
(Date:8/22/2014)... News) -- Back-to-school time provides an opportunity for parents ... family schedules, an expert suggests. "Forget New Year,s ... also be the start of a new fitness and ... kinesiology at the University of the Sciences in Philadelphia, ... extracurricular activities likely to build up, "it,s important for ...
(Date:8/22/2014)... Dayton Children's Hospital broke ground on a historic new, eight-story, ... campus renewal. Renderings of the exterior of ... , The new patient tower is part of a ... meets the needs of patients, families and care providers well ... Children’s unique patient care mission and offer places that facilitate ...
(Date:8/22/2014)... blockages in the kidney arteries may benefit patients ... trials, according to new recommendations for renal artery ... today by the Society for Cardiovascular Angiography ... Center,s Sahil Parikh, MD, Director, Interventional Cardiology Fellowship ... University School of Medicine was the lead author ...
(Date:8/22/2014)... 22, 2014 Menstrual leaks risk stains ... Sunrise, Fla., decided that there needed to be a ... use and producible in design variations, the Safety Net ... leaks, which avoids embarrassment and promotes peace of mind. ... pads. , The original design was submitted to the ...
Breaking Medicine News(10 mins):Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:With Kids in School, Parents Can Work Out 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3
... new studies show effects on angina and mortality , MONDAY, ... problems with the mind can play a significant role in ... and depression can increase the incidence of angina, the chest ... Mark Sullivan, professor of psychiatry and behavioral sciences at the ...
... of Affordable Health Insurance Urges for a Focus on Patient ... Fla., June 29 Cinergy Health, a nationwide ... consumer market, expressed its concern for America,s dependency on prescription ... , , "Michael Jackson,s untimely death is drawing attention ...
... ... the latest minimally invasive single as well as double hip replacement procedures. , ... (Vocus) June 29, 2009 -- Noted orthopedic ... the 135-year-old downtown hospital,s Medical Director of Joint Replacement and Reconstruction, Dr. Thomas Whitten, Chief ...
... nationally; largest network in four states , , KANSAS ... marketer of life, disability and dental group employee benefits based ... by nearly 20 percent in 2009, placing it in the ... than 112,000 referable locations nationwide, and is the largest network ...
... ... Allow Organizations to Gain Greater Risk Visibility, Simplify and Centralize Compliance Efforts while Trimming ... Scottsdale, ... endpoint security , has partnered with Network Frontiers , a leader in ...
... $60 Million Medicaid Funding Boost Merely Scratches Surface in Terms ... June 29 In summing up the 2009 session of ... session called by Governor Rick Perry, the Texas Health Care ... rate increase ($60 million general revenue) for Medicaid-financed nursing home ...
Cached Medicine News:Health News:Depression, Anxiety Bad for the Heart 2Health News:Depression, Anxiety Bad for the Heart 3Health News:Cinergy Health Commentary on America's Prescription Addiction 2Health News:Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center 2Health News:Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center 3Health News:Assurant Employee Benefits Expands Dental Network 2Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 2Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 3Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 4Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 5Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 6Health News:THCA on 2009 Legislative Session: Seniors' Medicaid-Financed Nursing Home Care Requires Substantially More Investment as Population Ages, Care Needs Grow 2
... For some sectioning work, it is necessary to ... State Freezer can be fitted to most microtomes ... -25C or lower, depending on conditions. The equipment ... unit. The cooling stage is best suited for ...
... MNL 4404 & 4405 series Freezing Stages fit ... have no moving parts and need only the ... for operation. Freezing starts immediately and ... adjustable so that optimum cutting temperatures can be ...
... 4405 series Freezing Stages fit easily onto most ... parts and need only the AC supply and ... Freezing starts immediately and can be maintained ... optimum cutting temperatures can be set for different ...
RIA kit for the quantitative determination of autoantibodies to IA-2 in serum...
Medicine Products: